Lung microbiota across age and disease stage in cystic fibrosis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Coburn, Bryan ^a   Wang, Pauline W ^b   Diaz Caballero, Julio ^a   Clark, Shawn T ^c   Brahma, Vijaya ^c   Donaldson, Sylva ^b   Zhang, Yu ^c   Surendra, Anu ^b   Gong, Yunchen ^b   Elizabeth Tullis, D ^d   Yau, Yvonne C W ^e,f   Waters, Valerie J ^f   Hwang, David M ^c,f   Guttman, David S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CFTR PROTEIN, HUMAN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; RNA 16S;

ADOLESCENT; ADULT; BIODIVERSITY; CHILD; CYSTIC FIBROSIS; FEMALE; GENETICS; HUMAN; LUNG; MALE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PRESCHOOL CHILD; PROSPECTIVE STUDY; SPUTUM; YOUNG ADULT;

ADOLESCENT; ADULT; BIODIVERSITY; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA, BACTERIAL; FEMALE; HUMANS; LUNG; MALE; MICROBIOTA; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; SPUTUM; YOUNG ADULT;

EID: 84929340326     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10241     Document Type: Article

References (35)

1. Kosorok, M. R. et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 32, 277-287 (2001).
2. Huang, N. N. et al. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am. J. Med 82, 871-879 (1987).
3. Lewin, L. O., Byard, P. J. & Davis, P. B. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J. Clin Epidemiol 43, 125-131 (1990).
4. Surette, M. G. The cystic fibrosis lung microbiome. Ann Am Thorac Soc 11 (Suppl 1), S61-65, doi:10.1513/AnnalsATS.201306-159MG (2014).
5. Delhaes, L. et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community - implications for therapeutic management. PLoS One 7, e36313, doi:10.1371/journal.pone.0036313 (2012).
6. Blainey, P. C., Milla, C. E., Cornfield, D. N. & Quake, S. R. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med 4, 153ra130, doi:10.1126/scitranslmed.3004458 (2012).
7. Stressmann, F. A. et al. Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers. J. Clin Microbiol 49, 281-291, doi:10.1128/JCM.01650-10 (2011).
8. Stressmann, F. A. et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 67, 867-873, doi:10.1136/thoraxjnl-2011-200932 (2012).
9. van der Gast, C. J. et al. Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J. 5, 780-791, doi:10.1038/ismej.2010.175 (2011).
10. Carmody, L. A. et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc 10, 179-187, doi:10.1513/AnnalsATS.201211-107OC (2013).
11. Zhao, J. et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc. Natl. Acad. Sci. USA 109, 5809-5814, doi:10.1073/pnas.1120577109 (2012).
12. Fodor, A. A. et al. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 7, e45001, doi:10.1371/journal.pone.0045001 (2012).
13. Tunney, M. M. et al. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax 66, 579-584, doi:10.1136/thx.2010.137281 (2011).
14. Sibley, C. D. et al. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci USA 105, 15070-15075, doi:10.1073/pnas.0804326105 (2008).
15. Rogers, G. B. et al. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann Am Thorac Soc 11, 496-503, doi:10.1513/AnnalsATS.201310-335OC (2014).
16. Klepac-Ceraj, V. et al. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 12, 1293-1303, doi:10.1111/j.1462-2920.2010.02173.x (2010).
17. Cox, M. J. et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 5, e11044, doi:10.1371/journal.pone.0011044 (2010).
18. Daniels, T. W. et al. Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis. J Cyst Fibros 12, 22-28, doi:10.1016/j.jcf.2012.05.008 (2013).
19. Filkins, L. M. et al. Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol 194, 4709-4717, doi:10.1128/JB.00566-12 (2012).
20. Zhao, J., Murray, S. & Lipuma, J. J. Modeling the impact of antibiotic exposure on human microbiota. Sci Rep 4, 4345, doi:10.1038/ srep04345 (2014).
21. Lyczak, J. B., Cannon, C. L. & Pier, G. B. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15, 194-222 (2002).
22. Kerem, E. et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry. Eur Respir J 43, 125-133, doi:10.1183/09031936.00166412 (2014).
23. Rogers, G. B. et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 68, 731-737, doi:10.1136/thoraxjnl-2012-203105 (2013).
24. Razvi, S. et al. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest 136, 1554-1560, doi:10.1378/chest.09-0132 (2009).
25. Bar-On, O. et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros, doi:10.1016/j.jcf.2014.05.008 (2014).
26. Zhao, J. et al. Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum. PLoS One 7, e33127, doi:10.1371/journal.pone.0033127 (2012).
27. Nadkarni, M. A., Martin, F. E., Jacques, N. A. & Hunter, N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148, 257-266 (2002).
28. Maughan, H. et al. Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions. PLoS One 7, e45791, doi:10.1371/journal.pone.0045791 (2012).
29. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335-336, doi:10.1038/nmeth.f.303 (2010).
30. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461, doi:10.1093/ bioinformatics/btq461 (2010).
31. Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25, 3389-3402 (1997).
32. Waters, V. et al. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis. J Cyst Fibros 11, 8-13, doi:10.1016/j.jcf.2011.07.008 (2012).
33. Quanjer, P. H. et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 40, 1324-1343, doi:10.1183/09031936.00080312 (2012).
34. Flegal, K. M. & Cole, T. J. Construction of LMS parameters for the Centers for Disease Control and Prevention 2000 growth charts. Natl Health Stat Report 63, 1-3 (2013).
35. Wright, C. M., Parker, L., Lamont, D. & Craft, A. W. Implications of childhood obesity for adult health: findings from thousand families cohort study. BMJ 323, 1280-1284 (2001).